BGM Group Ltd. cash flow statement
In fiscal 2025, BGM Group Ltd.'s operations generated −$2.4m of cash; it spent $1.6m on capital projects, leaving free cash flow of −$3.9m.
Cash flow statement
| Fiscal year | 2018Sept 2018 | 2019Sept 2019 | 2020Sept 2020 | 2021Sept 2021 | 2022Sept 2022 | 2023Sept 2023 | 2024Sept 2024 | 2025Sept 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 4 | −1 | 5 | 0 | 13 | 0 | 1 | −2 |
| Depreciation and amortisation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Stock-based pay | — | — | — | — | 0 | — | — | 10 |
| Capital spending | 1 | 1 | 0 | 1 | 2 | 0 | 0 | 2 |
| Free cash flow | 3 | −1 | 5 | −1 | 11 | 0 | 0 | −4 |
| Free cash flow after stock pay | — | — | — | — | 11 | — | — | −14 |
| Dividends paid | 1 | — | — | — | — | 2 | — | — |
| Shares issued | 0 | — | — | 24 | — | — | — | — |
Compare with peers
- IM Cannabis Corp. cash flow
- Cumberland Pharmaceuticals Inc cash flow
- Sunshine Biopharma Inc. cash flow
- Scilex Holding Co cash flow
- Biofrontera Inc. cash flow
Head to head: BGM vs IMCCBGM vs CPIXBGM vs SBFM
More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies